WiCON | Pharma China (Web Edition)

ONLINE ENQUIRY

WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com

WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com

Review of China's Late-Stage Global Innovative Drug Pipeline in 2025 By late 2025, over 30 homegrown Chinese innovative drugs have advanced into global mid-to-late-stage development, including Phase II, Phase III, or registration-stage tri...
(11/14/2025)

China's Biopharma Innovation Surges — McKinse... (11/21/2025)

US Report Flags Risks From China's Expanding C... (11/21/2025)

China Biopharma Tracker – October 2025 (Pharm... (11/20/2025)

China's Innovation-drug BD Boom Slows as Inves... (11/20/2025)

China's October Approvals Signal the Next Five... (11/18/2025)

China Biopharma Strikes Record USD 19.9 B in L... (11/18/2025)

MNCs Face Diverging Fortunes and Strategic Res... (11/14/2025)

Review of China's Late-Stage Global Innovative... (11/14/2025)

Innovative Antibody Therapeutic Development in... (11/13/2025)

China Wraps Up 2025 Drug Negotiation: Dual Cat... (11/5/2025)

MNCs Retreat as China Cancels Dozens of Brande... (11/5/2025)

Bloomberg: China Has Another Trade Weapon Wait... (11/5/2025)

Recent Executive Moves (11/21/2025) NMPA Issues New Rules on Inspections and... (11/21/2025) CSPC Advances Nectin-4 ADC SYS6002 Into ... (11/21/2025) RocRock Biotech Raises CNY 50M to Advanc... (11/21/2025) Lynk Reports Positive Phase II Results f... (11/21/2025) Xiangxue Expands Into In Vivo TCR-T Ther... (11/21/2025) Innovent Moves Toward China Filing After... (11/21/2025) Innovent's Mazdutide Achieves Strong Pha... (11/20/2025) GSK, LTZ Forge Strategic Alliance to Adv... (11/20/2025) NHC Issues the Guidelines for Strengthen... (11/20/2025) China Pilots Next-Generation AI Reforms ... (11/20/2025) CRO Boom Sweeps APAC as China Takes the ... (11/20/2025) China's Pharmaceutical Market Enters a N... (11/20/2025) Nona Biosciences Teams Up With Pfizer fo... (11/20/2025) China Accelerates Animal Testing in Ambi... (11/19/2025) CDE Solicits Comments on Technical Guide... (11/18/2025) CDE Issues the Technical Guidelines for ... (11/18/2025) NMPA Issues the 98th Batch of the Refere... (11/18/2025)

China's Pharmaceutical Market Enters a New Consumer-Dri... China's Aging Population to Drive Trillion-Dollar Healt... China's Innovative Drug Market Shows Diverging Trends B... Innovent's Weight-Loss Drug Challenges Western Giants i... China's PD-(L)1 Market Shows Continued Growth in H1 202...

Xiangxue Expands Into In Vivo TCR-T Therapy Through New... RocRock Biotech Raises CNY 50M to Advance Next-Gen CAR-... Nona Biosciences Teams Up With Pfizer for Next-Gen Anti... CRO Boom Sweeps APAC as China Takes the Lead GSK, LTZ Forge Strategic Alliance to Advance Novel Myel...

NMPA Issues New Rules on Inspections and Export Certifi... China Bets on Hong Kong's CMPR to Become a Global Regul... NMPA Issues the 98th Batch of the Reference Formulation... CDE Issues the Technical Guidelines for Clinical Trials... CDE Solicits Comments on Technical Guidelines for Commo...

China Pilots Next-Generation AI Reforms Across Public H... NHC Issues the Guidelines for Strengthening Service Cap... China Launches National Strategy to Integrate AI Across... China to Expand Use of Artificial Intelligence Across H... China Expands Drug Access Through 11th National Bulk-Bu...

BeOne and AbbVie Resolve Patent Dispute O... Several Chinese Biotech Firms Added to U.S. Entity List... Chinese Scientist Arrested in Houston Over Alleged Thef... U.S. Closes Bribery Investigation into GE Healthcare's ... SAMR Orders Simcere to Reverse Unnotified Merger Over C...

India and China Explore Reverse-Trade Model for Pharmac... Clariant Completes Expansion of Pharma Excipients and S... Sanofi Launches €1B Insulin API Manufacturing Project ... China Faces New Pressure as U.S. Eyes Middle East for D... FDA Issues Warning to Chengdu Biopharma Over cGMP Viola...

Innovent Moves Toward China Filing After High-Dose Obes... Lynk Reports Positive Phase II Results for Topical JAK ... CSPC Advances Nectin-4 ADC SYS6002 Into First Phase 3 T... Innovent's Mazdutide Achieves Strong Phase 3 Results in... China Accelerates Animal Testing in Ambitious Biotech P...

BioAtla and BeiGene Revise Global Deal for Novel Condit... Pfizer to Absorb Mylan, Creating Global Generic Powerho... PhRMA Calls for Trade Deals That Force Countries to Pay... IQVIA: Global Pharma to Grow Slower in the Next Five Ye... Pfizer and GSK Announce JV to Create a Global Consumer ...

Recent Executive Moves Recent Executive Moves Recent Executive Moves Senior CSPC Executive Fined CNY 5M for Insider Trading Recent Executive Moves

China Introduces Plan for Pudong New Area's Pilot Compr... Upcoming Event: 2023 Pharma CI USA Conference & Exhibit... Upcoming Event: 15th Annual Pharma Market Research Conf... Upcoming Event: 6th International Conference on Emergin... Upcoming Event: PHARM Connect Congress

Pharma China is the most influential English media and source of business intelligence covering the Chinese pharmaceutical and biopharmaceutical sector...

WiCON has been helping international healthcare companies succeed in China and other Asian markets since 1991. We advise our clients on every stage of their China and Asian business. We worked with clients in many regions of the world...

2023 Order Form + Product Descripti... WiCON Publishes the China Pharmaceu... WiCON Publishes the China Pharmaceu... WiCON Publishes the China Pharmaceu... WiCON Publishes the China Pharmaceu...